As such, many observational and non-controlled studies on TNF-a inhibitors have reported positive findings and suggest that these agents could lead to a reduction of cardiovascular events in patients with psoriasis [18,19,20,21,22,23,24,25,26,27,28]. The gene discussed is TNF; the disease is psoriasis.